Jagsonpal Pharmaceuticals Completes Acquisition of 85% Stake in Aequitas Healthcare Private Limited
Jagsonpal Pharmaceuticals Limited has successfully completed the acquisition of an 85% equity stake in Aequitas Healthcare Private Limited. This transaction follows a series of updates provided by the company regarding the proposed investment, which were initially announced on June 29, 2026, with subsequent progress reports shared on July 7, 2026, and July 8, 2026.The acquisition marks a significant milestone in the company's portfolio expansion as it secures the majority ownership in Aequitas Healthcare Private Limited. The completion of this transaction follows the formal proposal to acquire the specified equity stake, bringing the acquisition process to a conclusion.
JAGSNPHARM Stock Price Movement
Jagsonpal Pharmaceuticals Limited shares today slipped by 1.04% to settle at ₹224.08. The stock saw a total turnover of 33,634 shares as it traded within a daily range of ₹223.01 to ₹232.21.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.